Immuron Limited (IMRN)
| Bid | 2.13 |
| Market Cap | 12.24M |
| Revenue (ttm) | 7.29M |
| Net Income (ttm) | -5.25M |
| EPS (ttm) | -0.6 |
| PE Ratio (ttm) | -3.58 |
| Forward PE | -103 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.16 |
| Volume | 128,746 |
| Avg. Volume (20D) | 246,252 |
| Open | 2.13 |
| Previous Close | 2.06 |
| Day's Range | 2.05 - 2.16 |
| 52-Week Range | 1.50 - 2.73 |
| Beta | 0.44 |
| Ex-Dividend Date | n/a |
About IMRN
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for IMRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
2 years ago · newsfilecorp.com
Immuron Limited Announces Participation in the LD Micro Main Event XVIPresentation on Wednesday, October 4th at 11:00 PT Melbourne, Australia--(Newsfile Corp. - September 18, 2023) - Immuron Limited (NASDAQ: IMRN), an Australian based and globally integrated biopharmace...
2 years ago · proactiveinvestors.co.uk
Immuron CEO highlights strong sales growth in business update presentationImmuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steven Lydeamore highlighted the strong growth in sales of oral immunotherapeutic products in the company's February 2023 business update presentation for invest...
3 years ago · investorplace.com
IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron Soaring?Today marks one of the best days for IMRN stock in a long time, with shares surging nearly 50% on the back of some impressive news. The post IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron...
